$MEDI.c is having an excellent Q1 $MEDI.c is having an excellent Q1 reaching under $2M by the end of Oct 2021.
Since transitioning from an investment issuer to a single purpose company focused on consolidating medical clinics $MEDI.c reached $1,989,752 at the end of Q1.
$MEDI.c has become a leader in mental health treatments, with the assistance of their fully owned research organization KGK science Inc have secured a significant amount of new business.
$MEDI.c reeling in gross project of $594,411 in Q1, check out this article to learn more !
https://www.ketamine.one/releases/ketamine-one-reports-strong-1q22-financial-results
$MEDI.c trading at $0.39 a share, MC of $45M